×

Register now: Live webinar - Wednesday 21 January @ 12:30pm -

Event | Tax Advantaged Online Forum: Four distinct approaches to EIS investing

127: How to invest venture capital into manufacturing effectively | Stephane Mery & Hannah Wade of Everquest Capital Partners

13 Jan 2026 / Podcast Tax Advantaged

By Dr Brian Moretta

Deep maketech is not well known to investors, but is the theme that Everquest Capital Partners focus on. In this episode, Partners Stephane Mery and Hannah Wade discuss this blend of technology and manufacturing and its attractions to investors.

Amongst other topics, we talk about:

  • What deep maketech is;
  • What’s needed to make restoring of manufacturing work;
  • The current schemes around to support this;
  • Working with university spinouts;
  • How to help companies optimise manufacturing processes;
  • The challenge of building robust supply chains in the current environment;
  • Managing capital intensity in businesses;
  • Bringing the right partners on board;
  • How AI is being used.

Stephane and Hannah bring great insights with lots of real life examples from their investments. Enjoy!

Please email [email protected] if you have any questions or comments on The EIS Navigator.

Never miss an episode – click here to subscribe to The EIS Navigator on most popular services. 

Listen now

Links

Read more on Everquest Capital Partners website.

Suggested book

The Medici Effect by Frans Hohansson

Welcome to the War Economy by David Baverez

Bios

Dr Stephane Mery has over 20 years’ experience in private equity and entrepreneurship. He was CEO of BBSF, an early-stage fund behind the success of Spirogen (sold to Astra Zeneca for $400m) and Endomagnetics (sold for $310m to Hologic). He was also partner at Beringea, leading investments in Life Sciences and Renewables including Biovex (sold for $1bn to Amgen). Stephane turned around and successfully exited a company manufacturing and selling laboratory monitoring equipment. Stephane is a Doctor in Veterinary Medicine, a Veterinary Pathologist and holds an MBA from INSEAD.

Hannah Wade is a Partner and has over 20 years of experience. She is also Managing Director at CPI Enterprises and established CPI’s investor engagement and ventures arm in 2019. Under her leadership, CPI has built a strong portfolio of investments. Through her long engagement at CPI, she has developed a strong network within the innovation sector. She leverages this network to cultivate a strong pipeline of investment opportunities for investors, attract strategic partners and connect portfolio companies into the infrastructure and research organisation ecosystem for technical, business and funding support. She is also passionate about promoting female entrepreneurship and is a member of the Lifted Project’s North East board. A qualified lawyer, Hannah has a law degree from Leeds University and was a solicitor in private practice for nearly 10 years before joining CPI as in house legal counsel.

Disclaimer

Please note this podcast/interview does not constitute a financial promotion and is provided for informational purposes and should not be construed as an invitation or offer to buy or sell any investments. Please be aware that investments into unquoted companies are high risk, long term and illiquid investments.  Your capital is at risk. Past performance is not a reliable indicator of future performance.  Target returns are not guaranteed and forward looking statements are illustrative only and must not be relied upon. Investors should only invest on the basis of reading the full offer documentation. Listeners must make their own independent decisions and obtain their own independent advice regarding any information, projects, securities, tax treatment or financial instruments mentioned herein.